367
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of efflux pump activity of multidrug-resistant Salmonella Typhimurium isolated from poultry wet markets in India

, , , , , & show all
Pages 1081-1088 | Published online: 06 May 2019

References

  • Brenner FW, Villar RG, Angulo FJ, Tauxe R, Swaminathan B. Salmonella nomenclature. J Clin Microbiol. 2000;38:2465–2467.10878026
  • Issenhuth-Jeanjean S, Roggentin P, Mikoleit M, et al. Supplement 2008–2010 (no. 48) to the White–Kauffmann–Le minor scheme. Res Microbiol. 2014;165:526–530. doi:10.1016/j.resmic.2014.07.00425049166
  • Griffin AJ, McSorley SJ. Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda. Mucosal Immunol. 2011;4:371–382. doi:10.1038/mi.2011.221307847
  • Cohen JI, Bartlett JA, Corey GR. Extra-intestinal manifestations of Salmonella infections. Medicine (Baltimore). 1987;66:349–388. doi:10.1097/00005792-198709000-000033306260
  • Greig JD, Ravel A. Analysis of foodborne outbreak data reported internationally for source attribution. Int J Food Microbiol. 2009;130:77–87. doi:10.1016/j.ijfoodmicro.2008.12.03119178974
  • Bakshi CS, Singh VP, Malik M, Singh RK, Sharma B. 55 kb plasmid and virulence-associated genes are positively correlated with Salmonella Enteritidis pathogenicity in mice and chickens. Vet Res Commun. 2003;27:425–432.
  • Martins M, McCusker M, Amaral L, Fanning S. Mechanisms of antibiotic resistance in Salmonella: efflux pumps, genetics, quorum sensing and biofilm formation. Lett Drug Des Discov. 2011;8(2):114–123. doi:10.2174/157018011794183770
  • Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria. Drugs. 2009;69(12):1555–1623. doi:10.2165/11317030-000000000-0000019678712
  • Nikaido H. How do exported proteins and antibiotics bypass the periplasm in gram-negative bacterial cells? Trends Microbiol. 2000;8(11):481–483.11121749
  • Galan JE, Ginocchio C, Costeas P. Molecular and functional characterization of the Salmonella invasion gene invA: homology of invA to members of a new protein family. J Bacteriol. 1992;174:4338–4349.1624429
  • Alvarez J, Sota M, Vivanco A, et al. Development of a multiplex PCR technique for detection and epidemiological typing of Salmonella in human clinical samples. J Clin Microbiol. 2004;42:1734–1738. doi:10.1128/JCM.42.4.1734-1738.200415071035
  • Martins M, McCusker MP, Viveiros M, et al. A simple method for assessment of MDR bacteria for over-expressed efflux pumps. Open Microbiol J. 2013;7:72–82. doi:10.2174/187428580130701007223589748
  • Sun J, Deng Z, Yan A. Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations. Biochem Biophys Res Commun. 2014;2014(453):254–267. doi:10.1016/j.bbrc.2014.05.090
  • World Health Organization. Antimicrobial resistance: global report on surveillance. World Health Organization; 2014.
  • Pesingi PK, Kumawat M, Behera P, et al. Protein-l-isoaspartyl methyltransferase (PIMT) is required for survival of Salmonella Typhimurium at 42° C and contributes to the virulence in poultry. Front Microbiol. 2017;8:361. doi:10.3389/fmicb.2017.0036128326072
  • Mikanatha NM, Sandt CH, Localio AR, et al. Multidrug-resistant Salmonella isolates from retail chicken meat compared with human clinical isolates. Foodborne Pathog Dis. 2010;7:929–934. doi:10.1089/fpd.2009.049920443729
  • Majowicz SE, Musto J, Scallan E, et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis. 2010;50:882–889. doi:10.1086/65073320158401
  • European food safety authority and European centre for disease prevention and control. EU summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2013. EFSA J. 2015;13(2):4036.
  • National antimicrobial resistance monitoring system: the 2012–2013 integrated NARMS report; 2015 Available from: http://www.fda.gov/downloads/AnimalVeterinary/SafetyHealth/AntimicrobialResistance. Accessed April 24, 2019.
  • Asif M, Rahman H, Qasim M, et al. Molecular detection and antimicrobial resistance profile of zoonotic Salmonella Enteritidis isolated from broiler chickens in Kohat, Pakistan. J Chin Med Assoc. 2017;80:303–306. doi:10.1016/j.jcma.2016.11.00728286058
  • Giraud E, Baucheron S, Cloeckaert A. Resistance to fluoroquinolones in Salmonella: emerging mechanisms and resistance prevention strategies. Microb Infec. 2006;8(7):1937–1944. doi:10.1016/j.micinf.2005.12.025
  • Hopkins KL, Davies RH, Threlfall EJ. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agent. 2005;25(5):358–373. doi:10.1016/j.ijantimicag.2005.02.006
  • Giraud E, Cloeckaert A, Kerboeuf D, Chaslus-Dancla E. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother. 2000;44(5):1223–1228.10770755
  • Poole K. Efflux pumps as antimicrobial resistance mechanisms. Ann Med. 2007;39(3):162–176. doi:10.1080/0785389070119526217457715
  • Schumacher A, Trittler R, Bohnert JA, et al. Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation. Antimicrob Agents Chemother. 2006;59(6):1261–1264. doi:10.1093/jac/dkl380
  • Martins M, Santos B, Martins A, et al. An instrument-free method for the demonstration of efflux pump activity of bacteria. In vivo. 2006;20(5):657–664.17091774
  • Amaral L, Martins A, Spengler G, Molnar J. Efflux pumps of gram-negative bacteria: what they do, how they do it, with what and how to deal with them. Front Pharmacol. 2014;4:168. doi:10.3389/fphar.2013.0016824427138
  • Costa SS, Falcão C, Viveiros M, et al. Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Staphylococcus aureus. BMC Microbiol. 2011;11(1):241. doi:10.1186/1471-2180-11-24122032541
  • Rana T, Kaur N, Farooq U, et al. Efflux as an arising cause of drug resistance in Punjab-India. IJBPAS. 2015;4(9):5967–5979.
  • Kourtesi C, Ball AR, Huang YY, et al. Suppl 1: microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation. Open Microbiol. 2013;7:34–52. doi:10.2174/1874285801307010034
  • Li XZ, Plésiat P, Nikaido H. The challenge of efflux-mediated antibiotic resistance in gram-negative bacteria. Clin Microbiol Rev. 2015;28(2):337–418. doi:10.1128/CMR.00117-1425788514
  • Smith AM, Govender N, Keddy KH. Quinolone-resistant Salmonella Typhi in South Africa, 2003–2007. Epidemiol Infect. 2010;138(1):86–90. doi:10.1017/S095026880999033119563699
  • Nagano K, Nikaido H. Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli. Proc Natl Acad Sci. 2009;106(14):5854–5858. doi:10.1073/pnas.090169510619307562
  • Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol. 2014;5:643. doi:10.3389/fmicb.2014.0054725505462
  • Nikaido H, Pagès JM. Broad-specificity efflux pumps and their role in multidrug resistance of gram-negative bacteria. FEMS Microbiol Rev. 2012;36(2):340–363. doi:10.1111/j.1574-6976.2011.00290.x21707670
  • Sidhu K, Talbot M, Van Mil K, et al. Treatment with sub-inhibitory kanamycin induces adaptive resistance to aminoglycoside antibiotics via the AcrD multidrug efflux pump in Escherichia coli K-12. J Exp Microbiol Immunol. 2012;16:11–16.
  • Moreira MAS, Souza ECD, Moraes CAD. Multidrug efflux systems in gram-negative bacteria. Braz J Microbiol. 2004;35(1–2):19–28. doi:10.1590/S1517-83822004000100003
  • Tran JH, Jacoby GA. Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci. 2002;99(8):5638–5642. doi:10.1073/pnas.08209289911943863
  • Jacoby GA. Mechanisms of resistance to quinolones. Clin Infect Dis. 2005;41(Supplement_2):S120–S126. doi:10.1086/42805215942878